A.C. Correia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
A.C. Correia has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Ana Catarina Silva
UCIBIO, Laboratory of Pharmaceutical Technology, Faculty of Pharmacy, University of Porto, Porto, Portugal
2 shared publications - João Nuno Moreira
CNC-UC-Center for Neurosciences and Cell Biology, Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, Rua Larga—Faculdade de Medicina, 1ºandar—POLO I, 3004-504 Coimbra, Portugal
2 shared publications A. Hafner
University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, Croatia
1 shared publicationD. Zadravec
University Hospital Center "Sestre milosrdnice", University of Zagreb, School of Dental Medicine, Zagreb, Croatia
1 shared publication- Gonçalo Farias
Aptar Pharma, 27100 Le Vaudreuil, France
1 shared publication J.M. Sousa Lobo
University of Porto, UCIBIO, REQUIMTE, MEDTECH, Laboratory of Pharmaceutical Technology, Department, of Drug Sciences, Faculty of Pharmacy, Porto, Portugal; University of Porto, Associate Laboratory i4HB Institute for Health and Bioeconomy, Faculty of Pharmacy, Porto, Portugal
1 shared publication
Latest Publications
- Open Access
- 13 September 2025
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 684, 126166
Maximising olfactory deposition of a valproic acid (VPA)-loaded nanostructured lipid carriers (NLC) formulation
- 13 September 2025
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 684, 126166
Open AccessMaximising olfactory deposition of a valproic acid (VPA)-loaded nanostructured lipid carriers (NLC) formulation
- 12 November 2023
- Published by Taylor & Francis in Expert Opinion on Drug Delivery
- Vol. 20 (12) , 1731-1748
Design of experiment (DoE) as a quality by design (QbD) tool to optimise formulations of lipid nanoparticles for nose-to-brain drug delivery
The nose-to-brain route has been widely investigated to improve drug targeting to the central nervous system (CNS), where lipid nanoparticles (solid lipid nanoparticles - SLN and nanostructured lipid carriers - NLC) seem promising, although they should meet specific criteria of particle size (PS) < 200 nm, polydispersity index (PDI) < 0.3, zeta potential (ZP) ~|20| mV and encapsulation efficiency (EE) > 80%. To optimize SLN and NLC formulations, design of experiment (DoE) has been recommended as a quality by design (QbD) tool. This review presents recently published work on the optimization of SLN and NLC formulations for nose-to-brain drug delivery. The impact of different factors (or independent variables) on responses (or dependent variables) is critically analyzed. Different DoE have been used to optimize SLN and NLC formulations for nose-brain drug delivery, and the independent variables lipid and surfactant concentration and sonication time had the greatest impact on the dependent variables PS, EE and PDI. Exploring different DoE approaches is important to gain a deeper understanding of the factors that affect successful optimization of SLN and NLC and to facilitate future work improving machine learning techniques.
- 12 November 2023
- Published by Taylor & Francis in Expert Opinion on Drug Delivery
- Vol. 20 (12) , 1731-1748
Design of experiment (DoE) as a quality by design (QbD) tool to optimise formulations of lipid nanoparticles for nose-to-brain drug delivery
The nose-to-brain route has been widely investigated to improve drug targeting to the central nervous system (CNS), where lipid nanoparticles (solid lipid nanoparticles - SLN and nanostructured lipid carriers - NLC) seem promising, although they should meet specific criteria of particle size (PS) < 200 nm, polydispersity index (PDI) < 0.3, zeta potential (ZP) ~|20| mV and encapsulation efficiency (EE) > 80%. To optimize SLN and NLC formulations, design of experiment (DoE) has been recommended as a quality by design (QbD) tool. This review presents recently published work on the optimization of SLN and NLC formulations for nose-to-brain drug delivery. The impact of different factors (or independent variables) on responses (or dependent variables) is critically analyzed. Different DoE have been used to optimize SLN and NLC formulations for nose-brain drug delivery, and the independent variables lipid and surfactant concentration and sonication time had the greatest impact on the dependent variables PS, EE and PDI. Exploring different DoE approaches is important to gain a deeper understanding of the factors that affect successful optimization of SLN and NLC and to facilitate future work improving machine learning techniques.